Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2

• Główni autorzy: Hualou Liang (Autor), Liang Zhao (Autor), Xiajing Gong (Autor), Meng Hu (Autor), Hongbin Wang (Autor)
• Format: Książka
• Wydane: Wiley, 2021-05-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract The outbreak of the novel coronavirus severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2), the causative agent of coronavirus disease 2019 (COVID‐19) respiratory disease, led to a global pandemic with high morbidity and mortality. Despite frenzied efforts in therapeutic development...